YEXT · Yext, Inc.

Current Thesis

Yext’s margin-and-share-count recovery needs its artificial-intelligence products to restart recurring-revenue growth; the next quarterly report must show annual recurring revenue (ARR) above $440.8 million before a daily close below $5.90 invalidates the recovery thesis. The 2026-09-01 results established improved profitability, while the 2026-09-30 Envision conference provides the next dated opportunity for commercial evidence. Yext results; product announcement.

The narrative is maturing — the 2026-09-01 product announcements are established, while the adjusted reference close weakened to $6.14 on 2026-09-18 from $6.51 on 2026-09-04. That classification is an inference from the dated announcements and price observations, not evidence that participation has broadened. The case remains a legacy software pivot with unproven growth conversion.

Bullish and bearish views on Yext, Inc.

The model's bull view on Yext, Inc. (YEXT), in brief: Profitability provides tangible operating evidence. The bear view: Customer attrition still reduces revenue. Both cases follow in full.

Bull Case

• Profitability provides tangible operating evidence. Yext reported adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $34.0 million for the quarter ended 2026-07-31, alongside non-GAAP earnings per share of $0.21. These establish profitability, without establishing renewed revenue growth. 2026-09-01 results.
• Enterprise recurring revenue improved. The 2026-09-01 release reported enterprise ARR of $405.9 million against $399.3 million a year earlier, with enterprise net retention of 98% against 96%. Retention nevertheless remained below full replacement of the existing cohort’s revenue. Quarterly results.
• Product expansion has a date. Yext’s 2026-09-01 announcement scheduled Scout enhancements and Corvo AI for presentation at Envision on 2026-09-30. The event can establish product availability and commercial terms; a demonstration alone would not establish incremental ARR. Company announcement.

Bear Case

• Customer attrition still reduces revenue. The quarter ended 2026-07-31 generated revenue of $111.1 million against $113.1 million a year earlier. Management attributed the decline primarily to customer attrition in the September filing. Q2 FY2027 Form 10-Q.
• Recurring revenue has not restarted. The 2026-09-01 results reported total ARR of $440.8 million, unchanged sequentially. ARR from smaller customers was $34.9 million against $45.0 million a year earlier, limiting the evidence that enterprise improvement has repaired the whole business. Quarterly results.
• Acquisition cost is now explicit. The filing states that GoShine closed on 2026-06-14 for $1.1 million in cash, correcting the earlier description of an undisclosed purchase price. Its acquisition note does not quantify a separate revenue contribution. Form 10-Q, acquisition note.

Setup & Price Structure

The supplied adjusted market series records a $6.14 close on 2026-09-18, a three-month gain of 55.8%, and a 14-day relative strength index (RSI) of 27.7. These observations show weaker recent momentum within a positive three-month return; they do not establish a completed base or a reversal probability.

The $5.90 boundary retains the recovery threshold published on 2026-09-05. It is a research invalidation level, not a newly verified moving average or fresh support measurement. The 2026-09-18 close stands above that boundary, but the available observations do not establish every intervening close.

Positioning evidence is limited. The September results reported $150.9 million of corporate repurchases during the six months ended 2026-07-31 and 99.3 million shares outstanding at that date; those historical purchases do not establish continuing demand in September. Zacks published an earnings-estimate optimism article on 2026-09-07. One article is too small a sample to support a retail-crowding claim, and current short-interest, insider-flow and moving-average-distance measurements are missing. Zacks commentary.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Envision customer conference. Yext’s 2026-09-01 announcement confirms the date and product presentations. Disclosed paid adoption or attributable ARR would provide commercial evidence; another product presentation without financial measures would leave the growth thesis unresolved. Company announcement.

The previously estimated September filing event has already occurred: Yext’s filing index dates the quarterly report to 2026-09-01. A confirmed date for the next quarterly results is not established by the available announcements. SEC filing index.

What Would Change Our Mind

Loss of the published recovery boundary would end the price thesis: a daily close below $5.90 is the observable failure condition. The fundamental case succeeds only if the next reported total ARR exceeds the $440.8 million disclosed on 2026-09-01 before that price condition occurs. An unchanged or lower ARR reading would fail the growth test; Envision passing on 2026-09-30 without quantified commercial evidence would leave the event unable to confirm it.

The probability assessment is low because the 2026-09-18 momentum reading weakened while the latest reported ARR remained flat. Neither the available price observations nor the recent quarterly sample supports a calibrated historical success rate.

Correlation Notes

This is a single-name setup. The AI-enterprise-software tag describes Yext’s 2026-09-01 product agenda; it does not establish participation in a measured sector advance. No paired sector-return series is available alongside the 2026-09-18 price observations, so a correlation coefficient or claim that software peers explain the move is unsupported.